Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma.
- DOI
- 10.3389/fimmu.2026.1817862
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1817862,
title = {Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma.},
author = {Wang W and Chen T and Wang H and Zhao J and Yang C and Wu Y and Kong Y and Wang D and Li Y and Yang J and Xiang Y},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1817862},
url = {https://doi.org/10.3389/fimmu.2026.1817862}
}RIS
TY - JOUR TI - Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma. AU - Wang W AU - Chen T AU - Wang H AU - Zhao J AU - Yang C AU - Wu Y AU - Kong Y AU - Wang D AU - Li Y AU - Yang J AU - Xiang Y PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1817862 UR - https://doi.org/10.3389/fimmu.2026.1817862 ER -
APA
W, W., T, C., H, W., J, Z., C, Y., Y, W., Y, K., D, W., Y, L., J, Y., & Y, X. (2026). Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1817862
Source records
- pubmed · retrieved 2026-09-26T22:07:24.597Z